Skip to main content Skip to main navigation menu Skip to site footer

The effect of antihypertensive monotherapy and combination on blood pressure in stroke patients


Background: Stroke is a syndrome characterized by loss of focal and function of the rapidly developing CNS. Furthermore, hypertension is a known risk factor that occurs approximately 70% of the time, and lowering systolic BP from 1 to 3 mmHg effectively reduces the risk of stroke by 20 to 30%.

Methods: An observational analytic design, using a retrospective medical record data collection in Malang City Hospital. A total of 113 patients met the inclusion criteria. In addition, the inclusion criteria include hospitalized patients with a primary diagnosis of stroke, ischemia or bleeding as evidenced by a head CT scan, having comorbid hypertension, and having received antihypertensive therapy. Meanwhile, the exclusion criteria were the BP data of the patient measured only once.

Results: The results showed the ability of antihypertensive monotherapy and combinations to lower systolic BP by 33.62 ± 30.15 mmHg and 30.50 ± 29.47 mmHg (p = 0.744) in ischemic patients. In comparison, diastolic BP decreased by 6.86 ± 13.18 mmHg and 11.50 ± 16.26 mmHg (0.291), respectively. Moreover, the administration in bleeding stroke patients resulted in a decrease to 16.95 ± 17.89 mmHg and 22.82 ± 23.91 mmHg, (p = 0.029) for systolic, and 8.63 ± 14.63 mmHg and 8.71 ± 17.17 mmHg (p = 0.647) for diastolic BP, respectively. Furthermore, a combination of 4 antihypertensives drugs showed a better decrease in systolic BP in both patients (44.50 ± 21.63) compared to monotherapy, and a mixture of 2 as well as three drugs, by 27.02±27.05, 25.65 ± 29.97, and 25.37 ± 25.08 (p = 0.027), respectively.

Conclusions: Combination therapy is recommended in stroke patients because BP can be better controlled.     


  1. Carolei A. Transient ischemic attack and stroke: diagnosis, investigation and management. J Headache Pain. 2009;10:225. doi: 10.1007/s10194-009-0121-7.
  2. Geddes L, Hanson M, Roberts A, Ellis H, Standring S. Human anatomy the definitive visual guide. London: Dorling Kindersley Publishing; 2014. p. 1-256.
  3. Kelly EB. An overview of stroke. 1st ed. In: Gillard A, editor. New York: Greenhaven Press; 2013. p. 16-9.
  4. Holm SW, Cunningham LL, Bensadoun E, Madsen MJ. Hypertension: classification, pathophysiology, and management during outpatient sedation and local anesthesia. J Oral Maxillofac Surg. 2006;64:111-21. doi: 10.1016/j.joms.2005.09.023.
  5. Staessen JA, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA. 2003;289(18):2420–22.
  6. PERDOSSI, Guideline stroke tahun 2011. Jakarta: Perhimpunan Dokter Spesialis Saraf Indonesia (PERDOSSI); 2011. p. 1-131.
  7. Appleton JP, Sprigg N, Bath PM. Blood pressure management in acute stroke. Stroke Vasc. Neurol. 2016;1:72–82. doi: 10.1136/svn-2016-000020.
  8. Choudhury MJ, Chowdhury MT, Nayeem A, Jahan WA. Modifiable and non-modifiable risk factors of stroke: a review update. J Natl Inst Neurosci Bangladesh. 2015;1(1):22–6.
  9. Yu J, Zhou R, Cai G. From hypertension to stroke: mechanisms and potential prevention strategies. CNS Neurosci Ther. 2011;17:577–84. doi: 10.1111/j.1755-5949.2011.00264.x.
  10. Wengrofsky P, Lee J, Makaryus AN. Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease : implications for evaluation and targets for treatment of dyslipidemia Based on Recent Guidelines. IntechOpen; 2019. p. 1–31.
  11. Jane N, Nyakoojo A, Alice N, Nicholas B, Ddumba E. A descriptive epidemiological study on stroke in Kampala, Uganda: a hospital-based study. Afr J Neurol Sci. 2012;31(1):41–8.
  12. Angeli F, Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Staessen JA, et al. Calcium channel blockade to prevent stroke in hypertension. Am J Hypertens. 2004;17:817–22. doi: 10.1016/j.amjhyper.2004.06.002.
  13. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4(1):42–50. doi: 10.1016/j.jash.2010.02.005.
  14. Fares H, Dinicolantonio JJ, O'Keefe JH, Lavie CJ. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Hear. 2016:1–7. doi: 10.1136/openhrt-2016-000473.
  15. Bakris GL. Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker. J Clin Hypertens. 2008;10(1):27–32.
  16. Noubiap JJ. Effect of initial antihypertensive combination therapy on primary stroke prevention. J Thorac Dis. 2015;7(5):787–9. doi: 10.3978/j.issn.2072-1439.2015.05.06.
  17. Deswal A, Mann DL. Angiotensin receptor blockers in the treatment of heart failure. In: A. M. Feldman, editor. Heart failure: pharmacologic management. Hoboken: Blackwell Publishing; 2006. p. 44–56.

How to Cite

Yunita, E. P., Mayana, S. Q., & Afif, Z. (2022). The effect of antihypertensive monotherapy and combination on blood pressure in stroke patients. Bali Medical Journal, 11(1), 513–519.




Search Panel

Ema Pristi Yunita
Google Scholar
BMJ Journal

Saffana Qolby Mayana
Google Scholar
BMJ Journal

Zamroni Afif
Google Scholar
BMJ Journal